JAK3 and COVID-19: Reports suggest COVID-19 impacts Jak3 signaling and its inhibition in the immune cells may have potential beneficial effects (Rincon-Arevalo et al. 2022; Geng et al. 2021; Karki, et al. 2021; Li et al. 2021; Xia et al. 2020; Zhang, et al. 2022; Tran et al. 2021; Feng et al. 2022).